Dedicated to the discovery and optimization of adult stem cells for the treatment of a variety of diseases.

_____________________________________________________________________________________________________________________

The isolation of human adult stem cells marked the birth of a new era in biomedical research.  Their unique properties hold great promise for regenerative medicine, drug development and disease treatment. Today, approximately 40 diseases such as non-Hodgkin's lymphoma, acute lymphoblastic leukemia and sickle cell anemia are being treated successfully with cellular therapy. 

There are approximately 1,400 clinical trials underway that are positioned to make treatments for a number of indications a reality.  Parcell Laboratories' goal is to be the global leader in providing large quantities of adult stem cells to meet the demand for many of these therapeutic applications.  

One of our platform technologies is the ELA® stem cell, a unique osteoprogenitor adult stem cell that has the potential for use in a wide range of therapeutic applications.  Parcell is pursuing these applications in conjunction with world-class academic researchers and leading commercial biotechnology companies. 

 For more information about the future of our stem cell technologies, contact us at 781-686-9408 or info@parcelllabs.com.